Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma

Results of a phase II study investigating pembrolizumab combined with chemotherapy for treatment of relapsed Hodgkin lymphoma. (Abstract only)